Processing and Maturation of Cathepsin C Zymogen: A Biochemical and Molecular Modeling Analysis.


Journal

International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791

Informations de publication

Date de publication:
25 Sep 2019
Historique:
received: 19 08 2019
revised: 11 09 2019
accepted: 18 09 2019
entrez: 28 9 2019
pubmed: 29 9 2019
medline: 12 2 2020
Statut: epublish

Résumé

Cysteine cathepsin C (CatC) is a ubiquitously expressed, lysosomal aminopeptidase involved in the activation of zymogens of immune-cell-associated serine proteinases (elastase, cathepsin G, proteinase 3, neutrophil serine proteinase 4, lymphocyte granzymes, and mast cell chymases). CatC is first synthetized as an inactive zymogen containing an intramolecular chain propeptide, the dimeric form of which is processed into the mature tetrameric form by proteolytic cleavages. A molecular modeling analysis of proCatC indicated that its propeptide displayed a similar fold to those of other lysosomal cysteine cathepsins, and could be involved in dimer formation. Our in vitro experiments revealed that human proCatC was processed and activated by CatF, CatK, and CatV in two consecutive steps of maturation, as reported for CatL and CatS previously. The unique positioning of the propeptide domains in the proCatC dimer complex allows this order of cleavages to be understood. The missense mutation Leu172Pro within the propeptide region associated with the Papillon-Lefèvre and Haim-Munk syndrome altered the proform stability as well as the maturation of the recombinant Leu172Pro proform.

Identifiants

pubmed: 31557781
pii: ijms20194747
doi: 10.3390/ijms20194747
pmc: PMC6801622
pii:
doi:

Substances chimiques

Enzyme Precursors 0
Recombinant Proteins 0
Cathepsin C EC 3.4.14.1

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Références

J Mol Biol. 2002 Sep 20;322(3):559-68
pubmed: 12225749
Semin Immunopathol. 2013 Jul;35(4):411-21
pubmed: 23385856
Protein Expr Purif. 2019 May;157:21-27
pubmed: 30703555
Nat Genet. 1999 Dec;23(4):421-4
pubmed: 10581027
Biochim Biophys Acta. 2012 Jan;1824(1):68-88
pubmed: 22024571
Bioorg Med Chem Lett. 2009 Sep 15;19(18):5392-6
pubmed: 19665376
Biomol Concepts. 2013 Jun;4(3):287-308
pubmed: 25436581
J Biol Chem. 2018 Aug 10;293(32):12415-12428
pubmed: 29925593
Protein Sci. 1999 Feb;8(2):283-90
pubmed: 10048321
Science. 2013 Jan 11;339(6116):227-230
pubmed: 23196907
FEBS J. 2016 Feb;283(3):498-509
pubmed: 26607765
J Immunol. 2013 Sep 1;191(5):2700-7
pubmed: 23904161
Br J Dermatol. 2005 Feb;152(2):353-6
pubmed: 15727652
Biol Chem. 2003 Jun;384(6):837-43
pubmed: 12887050
Acta Biochim Pol. 2015;62(3):629-31
pubmed: 26317128
ACS Med Chem Lett. 2010 Nov 10;2(2):142-7
pubmed: 24900293
Bioinformatics. 2011 Jun 1;27(11):1575-7
pubmed: 21471012
J Immunol. 2004 Dec 15;173(12):7277-81
pubmed: 15585850
J Clin Invest. 2002 Feb;109(3):363-71
pubmed: 11827996
J Clin Invest. 2014 Oct;124(10):4539-48
pubmed: 25244098
Biochemistry. 2001 Feb 13;40(6):1671-8
pubmed: 11327826
Trends Pharmacol Sci. 2017 Oct;38(10):873-898
pubmed: 28668224
J Chem Theory Comput. 2010 Mar 9;6(3):890-909
pubmed: 20305729
J Med Genet. 1999 Dec;36(12):881-7
pubmed: 10593994
J Biol Chem. 2016 Apr 15;291(16):8486-99
pubmed: 26884336
Biol Chem. 2006 Aug;387(8):1143-6
pubmed: 16895486
Pharmacol Rev. 2010 Dec;62(4):726-59
pubmed: 21079042
Pharmacol Ther. 2018 Oct;190:202-236
pubmed: 29842917
EMBO J. 2001 Dec 3;20(23):6570-82
pubmed: 11726493
EMBO J. 1996 Oct 15;15(20):5492-503
pubmed: 8896443
J Biol Chem. 1998 Nov 27;273(48):32000-8
pubmed: 9822672
Mol Genet Genomic Med. 2014 May;2(3):217-28
pubmed: 24936511
J Med Genet. 2000 Feb;37(2):88-94
pubmed: 10662807
J Periodontol. 2002 Mar;73(3):307-312
pubmed: 29539009

Auteurs

Anne-Sophie Lamort (AS)

INSERM UMR-1100, CEPR (Centre d'Etude des Pathologies Respiratoires), 37032 Tours, France. anne-sophie.lamort@helmholtz-muenchen.de.
Université de Tours, 37032 Tours, France. anne-sophie.lamort@helmholtz-muenchen.de.
Comprehensive Pneumology Center and Institute for Lung Biology and Disease; University Hospital, Ludwig-Maximilians University of Munich and Helmholtz Center Munich; Member of the German Center for Lung Research, 81377 Munich, Germany. anne-sophie.lamort@helmholtz-muenchen.de.

Yveline Hamon (Y)

INSERM UMR-1100, CEPR (Centre d'Etude des Pathologies Respiratoires), 37032 Tours, France. yv.hamon@gmail.com.
Université de Tours, 37032 Tours, France. yv.hamon@gmail.com.

Cezary Czaplewski (C)

Faculty of Chemistry, University of Gdansk, 80-308 Gdansk, Poland. cezary.czaplewski@ug.edu.pl.

Artur Gieldon (A)

Faculty of Chemistry, University of Gdansk, 80-308 Gdansk, Poland. artur.gieldon@ug.edu.pl.

Seda Seren (S)

INSERM UMR-1100, CEPR (Centre d'Etude des Pathologies Respiratoires), 37032 Tours, France. seda.seren@etu.univ-tours.fr.
Université de Tours, 37032 Tours, France. seda.seren@etu.univ-tours.fr.

Laurent Coquet (L)

CNRS UMR-6270, Normandie Université, Plate-forme PISSARO, 76821 Mont Saint Aignan, France. laurent.coquet@univ-rouen.fr.

Fabien Lecaille (F)

INSERM UMR-1100, CEPR (Centre d'Etude des Pathologies Respiratoires), 37032 Tours, France. fabien.lecaille@univ-tours.fr.
Université de Tours, 37032 Tours, France. fabien.lecaille@univ-tours.fr.

Adam Lesner (A)

Faculty of Chemistry, University of Gdansk, 80-308 Gdansk, Poland. adam.lesner@ug.edu.pl.

Gilles Lalmanach (G)

INSERM UMR-1100, CEPR (Centre d'Etude des Pathologies Respiratoires), 37032 Tours, France. gilles.lalmanach@univ-tours.fr.
Université de Tours, 37032 Tours, France. gilles.lalmanach@univ-tours.fr.

Francis Gauthier (F)

INSERM UMR-1100, CEPR (Centre d'Etude des Pathologies Respiratoires), 37032 Tours, France. francis.gauthier@univ-tours.fr.
Université de Tours, 37032 Tours, France. francis.gauthier@univ-tours.fr.

Dieter Jenne (D)

Comprehensive Pneumology Center and Institute for Lung Biology and Disease; University Hospital, Ludwig-Maximilians University of Munich and Helmholtz Center Munich; Member of the German Center for Lung Research, 81377 Munich, Germany. dieter.jenne@helmholtz-muenchen.de.
Max Planck Institute of Neurobiology, 82152 Planegg-Martinsried, Germany. dieter.jenne@helmholtz-muenchen.de.

Brice Korkmaz (B)

INSERM UMR-1100, CEPR (Centre d'Etude des Pathologies Respiratoires), 37032 Tours, France. brice.korkmaz@inserm.fr.
Université de Tours, 37032 Tours, France. brice.korkmaz@inserm.fr.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH